<DOC>
	<DOCNO>NCT02253745</DOCNO>
	<brief_summary>The purpose research study evaluate safety , tolerability , effectiveness , pharmacokinetics ( PK ) twice daily oral dos V81444 adult ADHD . Pharmacokinetics ( PK ) study drug absorb , distribute , metabolize , eventually eliminate body . Pharmacokinetics body drug . Blood sample take throughout study PK analysis .</brief_summary>
	<brief_title>Safety , Tolerability , PK &amp; Efficacy V81444 Volunteers With Attention Deficit/ Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Subjects must : 1 . Be male female subject age 18 50 year inclusive 2 . Meet DSMIVTR criterion primary diagnosis ADHD combine , hyperactiveimpulsive predominantly inattentive type ; confirm minimum score 24 ADHDRS adult prompt : 3 . Have body mass index ( BMI ) 19 32 kg/m2 inclusive 4 . Be willing able comply requirement entire study 5 . Be able read understand English 6 . Give write informed consent 1 . Have significant medical condition history condition Investigator considers exclude subject study 2 . Have significant psychiatric disorder , determine Structured Clinical Interview DSMIVTR Axis I Disorders ( SCIDI ) 3 . Have know mental impairment define intelligence quotient ( IQ ) less 75 , clinical evidence mental impairment base opinion Investigator 4 . Have history evidence clinically significant GI disease , include ulcer , gastroesophageal reflux disease , hiatus hernia gastritis 5 . Have previous gastric surgery and/or bariatric procedure 6 . Have know malformation would make EGD difficult unsafe 7 . Have take prohibit concomitant medication 8 . Have multiple drug allergy allergic component V81444 study medication match placebo ( see Section 7.1 ) lidocaine 9 . Have abuse drug 12 month study drug administration 10 . In 90 day study drug administration , average smoke 5 cigarette per day consume 28 unit alcohol per week consume 500 mg caffeine per day 11 . In 2 calendar month study drug administration donate blood plasma excess 500 mL expose new investigational agent 12 . In calendar month prior screen use nonsteroidal antiinflammatory drug regularly new tattoo body pierce 13 . Have clinically relevant abnormal finding Screening and/or admission 14 . Plan undergo elective procedures/surgery time study 15 . Have condition might increase risk individual decrease chance obtain satisfactory data , assess Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit/ Hyperactivity Disorder</keyword>
</DOC>